Patent: 10,370,374
✉ Email this page to a colleague
Summary for Patent: 10,370,374
Title: | Heterocyclic compounds and uses thereof |
Abstract: | Provided herein are heterocyclic compounds of Formula (I), pharmaceutical compositions containing such a compound and their therapeutic uses, methods for their preparation, intermediate compounds, pharmaceutical compositions containing such a compound, and their therapeutic uses. |
Inventor(s): | Ibrahim; Prabha N. (Mountain View, CA), Spevak; Wayne (Berkeley, CA), Zhang; Jiazhong (Foster City, CA), Shi; Songyuan (Fremont, CA), Powell; Ben (Pleasant Hill, CA), Ma; Yan (Belmont, CA) |
Assignee: | Plexxikon Inc. (Berkeley, CA) |
Application Number: | 15/977,772 |
Patent Claims: | see list of patent claims |
Details for Patent 10,370,374
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2035-09-21 |
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2035-09-21 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2035-09-21 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2035-09-21 |
Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 05/07/2001 | ⤷ Try a Trial | 2035-09-21 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |